Chronic myelogenous leukemia (CML), also called chronic myeloid leukemia, is a blood cancer that starts in the bone marrow—the soft, spongy tissue inside bones where blood cells are made. CML is characterized by the uncontrolled growth of myeloid cells (a type of white blood cell). The hallmark of CML is a genetic change called the Philadelphia chromosome, which creates an abnormal BCR-ABL1 gene that drives the disease. The good news is that with modern targeted medicines, most people with CML live long, active lives, and many achieve deep, long-term remissions.

Ovarian cancer is a group of cancers that begin in or near the ovaries. Because the ovaries sit deep in the pelvis and early symptoms can be subtle, the disease is sometimes diagnosed after it has spread within the abdomen. Even so, outcomes continue to improve with modern surgery, platinum-based chemotherapy, targeted maintenance therapies, and coordinated multidisciplinary care.

Invasive lobular carcinoma (ILC) is the second most common type of breast cancer, after invasive ductal carcinoma. It begins in the milk-producing glands of the breast, called lobules, and then spreads to surrounding breast tissue. Over time, it can also spread (metastasize) to other parts of the body through the lymph nodes or bloodstream.

Ductal carcinoma in situ (DCIS) is a very early form of breast cancer. It begins in the milk ducts of the breast but does not spread outside them. Because it has not invaded nearby breast tissue, DCIS is often called "non-invasive breast cancer" or "stage 0 breast cancer".

Childhood blood cancer refers to cancers that start in the blood and bone marrow—the soft tissue inside bones where new blood cells are made. While the term sounds alarming, many children with blood cancers respond very well to modern treatments and go on to lead healthy, active lives. Early detection, expert pediatric oncology care, and compassionate support make a powerful difference. This comprehensive article explains childhood blood cancer in clear - what it is, how it’s diagnosed, treatment options, recovery at Apollo Hospitals.

Central nervous system (CNS) lymphoma is a rare cancer that starts in or spreads to the brain, spinal cord, eyes (vitreoretinal lymphoma), or the coverings of the brain and spinal cord (meninges). It is most often a type of non-Hodgkin lymphoma called diffuse large B-cell lymphoma (DLBCL). While the diagnosis can feel overwhelming, timely, coordinated care has significantly improved outcomes. This article explains CNS lymphoma - what it is, who gets it, symptoms to watch for, how it's diagnosed and treated, recovery and follow-up at Apollo Hospitals.

Overview: What Are Adrenal Gland Tumors?

The adrenal glands are two small organs that sit on top of the kidneys. Despite their size, they play a major role in controlling hormones that regulate blood pressure, metabolism, stress response, and other essential body functions. An adrenal gland tumor is an abnormal growth in one or both adrenal glands. Adrenal gland tumors may be non-cancerous (benign) or cancerous (malignant). Most are found by chance on scans for other reasons. The aggressive form, called adrenocortical carcinoma, is very rare but needs urgent treatment.

Invasive ductal carcinoma (IDC) is the most common type of breast cancer, making up nearly 80% of all cases. It starts in the milk ducts of the breast and spreads into nearby breast tissue. From there, it may spread to lymph nodes or other parts of the body if not detected early. Because IDC is so common, doctors and researchers have developed many effective ways to diagnose and treat it. The good news is that with early detection, survival rates are high, and treatment can often preserve both health and quality of life.

Hypopharyngeal cancer is a rare but serious head and neck cancer that starts in the lower part of the throat, just behind the voice box (larynx). While it’s not among the most common cancers, it often presents late because early symptoms can be subtle. The good news is that with timely diagnosis and a coordinated, expert treatment plan, many people can achieve good control of the disease and maintain a strong quality of life.

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare type of lymphoma (cancer of the immune system) that can develop in the scar tissue and fluid surrounding a breast implant. It is not a breast carcinoma but a rare T-cell lymphoma that arises in the capsule and fluid surrounding the implant. Most reported cases are associated with textured implants, with a latency period typically of 7–10 years, though cases as early as 2 years and as late as >20 years have been described.